NIVFW
Income statement / Annual
Last year (2023), NewGenIvf Group Limited's total revenue was $5.14 M,
a decrease of 13.59% from the previous year.
In 2023, NewGenIvf Group Limited's net income was $130,193.00.
See NewGenIvf Group Limited’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$5.14 M
|
$5.94 M
|
$4.12 M
|
Cost of Revenue |
$3.45 M |
$4.41 M |
$3.09 M |
Gross Profit |
$1.68 M |
$1.54 M |
$1.02 M |
Gross Profit Ratio |
0.33 |
0.26 |
0.25 |
Research and Development
Expenses |
$0.00
|
$0.00
|
$0.00
|
General & Administrative
Expenses |
$1.62 M
|
$1.10 M
|
$801,329.00
|
Selling & Marketing
Expenses |
$18,030.00
|
$36,194.00
|
$24,693.00
|
Selling, General &
Administrative Expenses |
$1.64 M
|
$1.14 M
|
$826,022.00
|
Other Expenses |
$111,837.00 |
$23,019.00 |
$45,652.00 |
Operating Expenses |
$1.64 M |
$1.14 M |
$826,022.00 |
Cost And Expenses |
$5.09 M |
$5.55 M |
$3.92 M |
Interest Income |
$518.00 |
$21.00 |
$63.00 |
Interest Expense |
$46,179.00 |
$77,757.00 |
$88,289.00 |
Depreciation &
Amortization |
$229,708.00
|
$303,944.00
|
$342,539.00
|
EBITDA |
$384,305.00
|
$725,689.00
|
$587,012.00
|
EBITDA Ratio |
0.07 |
0.12 |
0.14 |
Operating Income Ratio
|
0.01
|
0.07
|
0.05
|
Total Other
Income/Expenses Net |
$111,837.00
|
$23,019.00
|
$45,652.00
|
Income Before Tax |
$108,418.00 |
$343,988.00 |
$156,184.00 |
Income Before Tax Ratio
|
0.02
|
0.06
|
0.04
|
Income Tax Expense |
$136,241.00 |
$208,141.00 |
$294,716.00 |
Net Income |
$130,193.00 |
$458,667.00 |
-$533.00 |
Net Income Ratio |
0.03 |
0.08 |
-0 |
EPS |
0 |
0 |
0 |
EPS Diluted |
0 |
0 |
0 |
Weighted Average Shares
Out |
$0.00
|
$0.00
|
$0.00
|
Weighted Average Shares
Out Diluted |
$0.00
|
$0.00
|
$0.00
|
Link |
|
|
|